is a partner in Kirkland’s London IP Litigation practice. Her practice is focused primarily on patent litigation, particularly in the life sciences and tech sectors. Katie has litigated patents across a broad spectrum of technological-subject matters including those relating to antibody and other protein biologics, biological product development and screening platforms, checkpoint inhibitor immunotherapies, diagnostics and next generation sequencing technologies, wireless and mobile telecommunications, and e-cigarette/vaping technologies. She is a member of AIPPI, PTMG and IPSoc, and is the Kirkland contact for the Intellectual Property Lawyers Association (IPLA).
Chambers and Partners make no representation or endorsement of the quality and services supplied
by companies or firms that may be found on this website. In no event will Chambers and Partners
be liable for any damages including, without limitation, indirect or consequential damages,
or any damages whatsoever arising from use or loss of use, data, or profits, whether in action
of contract, negligence or other tort action, arising out of or in connection with the use
of the website.